Law360, New York (March 7, 2012, 1:13 PM EST) -- A unit of Enzo Biochem Inc. on Tuesday hit Abbott Laboratories, Becton Dickinson & Co. and Hologic Inc. with separate patent infringement suits in Delaware federal court, alleging that the biotechnology companies used protected technology in their DNA-based diagnostic tools.
The suit adds the three to an expanding list of companies that the Enzo division, Enzo Life Sciences Inc., has gone after for allegedly infringing its gene-mapping patent.
The patent-in-suit — U.S. Patent Number 6,922,180 — covers technology for nucleic acid, or DNA, probes that can...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.